vs
Side-by-side financial comparison of Option Care Health, Inc. (OPCH) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.
Option Care Health, Inc. is the larger business by last-quarter revenue ($1.4B vs $1.4B, roughly 1.1× PACS Group, Inc.). PACS Group, Inc. runs the higher net margin — 4.4% vs 3.6%, a 0.8% gap on every dollar of revenue. On growth, PACS Group, Inc. posted the faster year-over-year revenue change (18.4% vs 12.2%). Over the past eight quarters, PACS Group, Inc.'s revenue compounded faster (20.5% CAGR vs 13.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
OPCH vs PACS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.4B |
| Net Profit | $51.8M | $59.7M |
| Gross Margin | 19.0% | — |
| Operating Margin | 5.9% | 7.0% |
| Net Margin | 3.6% | 4.4% |
| Revenue YoY | 12.2% | 18.4% |
| Net Profit YoY | -3.8% | 3022.5% |
| EPS (diluted) | $0.32 | $0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.4B | ||
| Q3 25 | $1.4B | $1.3B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.3B | $1.1B | ||
| Q3 24 | $1.3B | $1.0B | ||
| Q2 24 | $1.2B | $981.4M | ||
| Q1 24 | $1.1B | $934.3M |
| Q4 25 | — | $59.7M | ||
| Q3 25 | $51.8M | $52.4M | ||
| Q2 25 | $50.5M | $51.0M | ||
| Q1 25 | $46.7M | $28.5M | ||
| Q4 24 | $60.1M | $1.9M | ||
| Q3 24 | $53.9M | $15.6M | ||
| Q2 24 | $53.0M | $-10.9M | ||
| Q1 24 | $44.8M | $49.1M |
| Q4 25 | — | — | ||
| Q3 25 | 19.0% | — | ||
| Q2 25 | 19.0% | — | ||
| Q1 25 | 19.7% | — | ||
| Q4 24 | 21.3% | — | ||
| Q3 24 | 20.1% | 17.1% | ||
| Q2 24 | 20.3% | 22.3% | ||
| Q1 24 | 20.8% | 21.2% |
| Q4 25 | — | 7.0% | ||
| Q3 25 | 5.9% | 6.4% | ||
| Q2 25 | 5.8% | 6.2% | ||
| Q1 25 | 5.9% | 3.8% | ||
| Q4 24 | 6.9% | 1.7% | ||
| Q3 24 | 6.7% | 2.2% | ||
| Q2 24 | 6.6% | 0.1% | ||
| Q1 24 | 6.0% | 8.6% |
| Q4 25 | — | 4.4% | ||
| Q3 25 | 3.6% | 3.9% | ||
| Q2 25 | 3.6% | 3.9% | ||
| Q1 25 | 3.5% | 2.2% | ||
| Q4 24 | 4.8% | 0.2% | ||
| Q3 24 | 4.2% | 1.5% | ||
| Q2 24 | 4.3% | -1.1% | ||
| Q1 24 | 3.9% | 5.3% |
| Q4 25 | — | $0.42 | ||
| Q3 25 | $0.32 | $0.32 | ||
| Q2 25 | $0.31 | $0.31 | ||
| Q1 25 | $0.28 | $0.17 | ||
| Q4 24 | $0.36 | $-0.03 | ||
| Q3 24 | $0.31 | $0.10 | ||
| Q2 24 | $0.30 | $-0.07 | ||
| Q1 24 | $0.26 | $0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $309.8M | $197.0M |
| Total DebtLower is stronger | $1.2B | $353.2M |
| Stockholders' EquityBook value | $1.4B | $946.8M |
| Total Assets | $3.5B | $5.6B |
| Debt / EquityLower = less leverage | 0.86× | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $197.0M | ||
| Q3 25 | $309.8M | $355.7M | ||
| Q2 25 | $198.8M | $294.2M | ||
| Q1 25 | $171.4M | $287.5M | ||
| Q4 24 | $412.6M | $157.7M | ||
| Q3 24 | $483.0M | $49.5M | ||
| Q2 24 | $376.9M | $73.4M | ||
| Q1 24 | $219.5M | $81.2M |
| Q4 25 | — | $353.2M | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | $411.9M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
| Q4 25 | — | $946.8M | ||
| Q3 25 | $1.4B | $871.3M | ||
| Q2 25 | $1.4B | $806.8M | ||
| Q1 25 | $1.4B | $750.2M | ||
| Q4 24 | $1.4B | $709.6M | ||
| Q3 24 | $1.4B | $660.0M | ||
| Q2 24 | $1.4B | $572.1M | ||
| Q1 24 | $1.4B | $128.0M |
| Q4 25 | — | $5.6B | ||
| Q3 25 | $3.5B | $5.6B | ||
| Q2 25 | $3.4B | $5.5B | ||
| Q1 25 | $3.3B | $5.5B | ||
| Q4 24 | $3.4B | $5.2B | ||
| Q3 24 | $3.4B | $4.5B | ||
| Q2 24 | $3.3B | $3.9B | ||
| Q1 24 | $3.2B | $3.9B |
| Q4 25 | — | 0.37× | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 0.82× | — | ||
| Q1 25 | 0.82× | — | ||
| Q4 24 | 0.79× | 0.58× | ||
| Q3 24 | 0.78× | — | ||
| Q2 24 | 0.79× | — | ||
| Q1 24 | 0.74× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $139.4M | $-3.4M |
| Free Cash FlowOCF − Capex | $130.2M | — |
| FCF MarginFCF / Revenue | 9.1% | — |
| Capex IntensityCapex / Revenue | 0.6% | — |
| Cash ConversionOCF / Net Profit | 2.69× | -0.06× |
| TTM Free Cash FlowTrailing 4 quarters | $220.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-3.4M | ||
| Q3 25 | $139.4M | $204.8M | ||
| Q2 25 | $90.3M | $52.6M | ||
| Q1 25 | $-7.2M | $150.2M | ||
| Q4 24 | $36.1M | $64.6M | ||
| Q3 24 | $160.4M | $209.2M | ||
| Q2 24 | $195.7M | $34.8M | ||
| Q1 24 | $-68.8M | $58.8M |
| Q4 25 | — | — | ||
| Q3 25 | $130.2M | — | ||
| Q2 25 | $81.2M | — | ||
| Q1 25 | $-16.6M | — | ||
| Q4 24 | $25.8M | — | ||
| Q3 24 | $150.7M | — | ||
| Q2 24 | $185.9M | — | ||
| Q1 24 | $-74.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | 5.7% | — | ||
| Q1 25 | -1.2% | — | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | 11.8% | — | ||
| Q2 24 | 15.1% | — | ||
| Q1 24 | -6.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.5% | — |
| Q4 25 | — | -0.06× | ||
| Q3 25 | 2.69× | 3.91× | ||
| Q2 25 | 1.79× | 1.03× | ||
| Q1 25 | -0.15× | 5.28× | ||
| Q4 24 | 0.60× | 33.78× | ||
| Q3 24 | 2.98× | 13.39× | ||
| Q2 24 | 3.69× | — | ||
| Q1 24 | -1.54× | 1.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
PACS
Segment breakdown not available.
